Literature DB >> 18809938

In vitro and in vivo validation of ligA and tarI as essential targets in Staphylococcus aureus.

Karin Streker1, Tina Schäfer, Christoph Freiberg, Heike Brötz-Oesterhelt, Jörg Hacker, Harald Labischinski, Knut Ohlsen.   

Abstract

A conditional expression system has been developed using the isopropyl-beta-d-thiogalactopyranoside (IPTG)-inducible Pspac promoter to validate essential genes of Staphylococcus aureus in vivo. The system has been applied to prove the essentiality of ligA and to evaluate the function of tarI, which was found to be essential in vitro but not in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809938      PMCID: PMC2592864          DOI: 10.1128/AAC.00548-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.

Authors:  Christopher J Thomson; Edward Power; Helga Ruebsamen-Waigmann; Harald Labischinski
Journal:  Curr Opin Microbiol       Date:  2004-10       Impact factor: 7.934

2.  Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.

Authors:  F S Kaczmarek; R P Zaniewski; T D Gootz; D E Danley; M N Mansour; M Griffor; A V Kamath; M Cronan; J Mueller; D Sun; P K Martin; B Benton; L McDowell; D Biek; M B Schmid
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

3.  A method for demonstrating gene essentiality in Staphylococcus aureus.

Authors:  M Jana; T T Luong; H Komatsuzawa; M Shigeta; C Y Lee
Journal:  Plasmid       Date:  2000-07       Impact factor: 3.466

4.  Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Authors:  M Kuroda; T Ohta; I Uchiyama; T Baba; H Yuzawa; I Kobayashi; L Cui; A Oguchi; K Aoki; Y Nagai; J Lian; T Ito; M Kanamori; H Matsumaru; A Maruyama; H Murakami; A Hosoyama; Y Mizutani-Ui; N K Takahashi; T Sawano; R Inoue; C Kaito; K Sekimizu; H Hirakawa; S Kuhara; S Goto; J Yabuzaki; M Kanehisa; A Yamashita; K Oshima; K Furuya; C Yoshino; T Shiba; M Hattori; N Ogasawara; H Hayashi; K Hiramatsu
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

5.  Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus.

Authors:  R Novick
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

6.  Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway.

Authors:  Michael A D'Elia; Mark P Pereira; Yu Seon Chung; Wenjun Zhao; Andrew Chau; Teresa J Kenney; Mark C Sulavik; Todd A Black; Eric D Brown
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

7.  Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.

Authors:  Jagath L Kadurugamuwa; Lin V Sin; Jun Yu; Kevin P Francis; Richard Kimura; Tony Purchio; Pamela R Contag
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Staphylococcus aureus mevalonate kinase: isolation and characterization of an enzyme of the isoprenoid biosynthetic pathway.

Authors:  Natalya E Voynova; Sandra E Rios; Henry M Miziorko
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

9.  Direct continuous method for monitoring biofilm infection in a mouse model.

Authors:  Jagath L Kadurugamuwa; Lin Sin; Eddie Albert; Jun Yu; Kevin Francis; Monica DeBoer; Michael Rubin; Carole Bellinger-Kawahara; T R Parr; Pamela R Contag
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function.

Authors:  Magdalena Zalacain; Sanjoy Biswas; Karen A Ingraham; Jennifer Ambrad; Alexander Bryant; Alison F Chalker; Serban Iordanescu; Jing Fan; Frank Fan; R Dwayne Lunsford; Karen O'Dwyer; Leslie M Palmer; Chi So; Daniel Sylvester; Craig Volker; Patrick Warren; Damien McDevitt; James R Brown; David J Holmes; Martin K R Burnham
Journal:  J Mol Microbiol Biotechnol       Date:  2003
View more
  6 in total

1.  Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase.

Authors:  Steven Howard; Nader Amin; Andrew B Benowitz; Elisabetta Chiarparin; Haifeng Cui; Xiaodong Deng; Tom D Heightman; David J Holmes; Anna Hopkins; Jianzhong Huang; Qi Jin; Constantine Kreatsoulas; Agnes C L Martin; Frances Massey; Lynn McCloskey; Paul N Mortenson; Puja Pathuri; Dominic Tisi; Pamela A Williams
Journal:  ACS Med Chem Lett       Date:  2013-10-18       Impact factor: 4.345

Review 2.  Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.

Authors:  Coral González-Prieto; Cammie F Lesser
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

3.  Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform.

Authors:  Geetika Sethi; Gaurav Chopra; Ram Samudrala
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

Review 4.  Wall teichoic acid function, biosynthesis, and inhibition.

Authors:  Jonathan G Swoboda; Jennifer Campbell; Timothy C Meredith; Suzanne Walker
Journal:  Chembiochem       Date:  2010-01-04       Impact factor: 3.164

5.  Mechanistic assessment of DNA ligase as an antibacterial target in Staphylococcus aureus.

Authors:  Steven D Podos; Jane A Thanassi; Michael J Pucci
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

6.  An IPTG Inducible Conditional Expression System for Mycobacteria.

Authors:  Sudha Ravishankar; Anisha Ambady; Haripriya Ramu; Naina Vinay Mudugal; Ragadeepthi Tunduguru; Anand Anbarasu; Umender K Sharma; Vasan K Sambandamurthy; Sudha Ramaiah
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.